This is a case of a 31-year-old female who presented to the emergency department at a London teaching hospital with a 24-h history of visual loss following an assault. The ophthalmological routine examination showed a submacular hemorrhage (SMH), and a computerized tomography scan demonstrated a displaced orbital floor fracture with inferior rectus entrapment and a medial wall fracture. To induce displacement of the SMH, intravitreal injection of 0.25 μg tissue plasminogen activator (tPA) was combined with 0.3 mL of intravitreal 100% perfluoropropane (CF) gas. At the 1-day follow-up, there was an inferotemporal displacement of the blood clot, and visual acuity improved from hand motions to 6/5 within 3 months. No complications occurred over 2 years of follow-up, with a final visual acuity of 6/5. This case shows us that intravitreal tPA and gas appear safe and effective as a treatment for traumatic SMHs. Furthermore, our results demonstrate that prompt treatment leads to favorable anatomical and functional outcomes.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10619997 | PMC |
| http://dx.doi.org/10.1159/000534199 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Acute Submacular Hemorrhage Resulting from Neovascular Age-Related Macular Degeneration in a Monocular Patient.
J Vitreoretin Dis
December 2024
Duke Eye Center, Duke University School of Medicine, Durham, NC, USA.
To present the management and outcomes of a case of acute submacular hemorrhage due to neovascular age-related macular degeneration (nAMD). A single case was retrospectively evaluated. A 79-year-old man with a history of submacular hemorrhage from nAMD and persistent disease activity in the left eye presented with acute submacular hemorrhage in his better-seeing right eye, which was previously closely monitored for an extrafoveal serous pigment epithelial detachment without exudation.
View Article and Find Full Text PDFComparison of different treatment options in submacular haemorrhage.
BMC Ophthalmol
December 2024
Department of Ophthalmology, University of Ulm, Prittwitzstr. 43, 89075, Ulm, Germany.
Background/aims: Submacular haemorrhages (SMH) cause significant visual impairment. Until now, the comparative effectiveness of different treatment approaches remains inconclusive without clear treatment guidelines. The aim of our study was to evaluate the effectiveness of 5 surgical treatment modalities in terms of visual prognosis and success rate.
View Article and Find Full Text PDFCharacteristics of submacular hemorrhage with bacillary layer detachment and intrabacillary hemorrhage.
Eur J Ophthalmol
November 2024
Department of Retina-Vitreous, Narayana Nethralaya, Benguluru, India.
Purpose: To study the outcomes of patients presenting with submacular hemorrhage (SMH) and bacillary layer detachment (BALAD) following intervention.
Methods: This retrospective study examined fundus photographs and optical coherence tomography (OCT) scans to identify treatment-naive SMH and BALAD cases. Two groups were formed: SMH cases with and without BALAD.
Correlation between subretinal tissue plasminogen activator and air injection rates with pressure in a retina mimicking model.
Sci Rep
October 2024
Department of Ophthalmology, College of Medicine, Konkuk University, Konkuk University Medical Center, Seoul, 05030, Republic of Korea.
Article Synopsis
- - This study investigates how different injection rates and pressures of a fluid called tPA and air affect subretinal tissue using a special system and a model that simulates retina conditions.
- - A model was created using agarose to simulate submacular hemorrhage (SMH) and the results showed that the size of the simulated hemorrhage increased after fluid injections, with specific rates of injection recorded for both BSS (balanced salt solution) and air at varying pressures.
- - The researchers determined that a pressure of 12 psi is the minimum needed for effective fluid injection and 2 psi for air, which are important findings for improving surgical safety and preventing severe damage during procedures.
Submacular hemorrhage: My personal journey to the goal.
Graefes Arch Clin Exp Ophthalmol
October 2024
Department of Ophthalmology, Shiga University of Medical Science, Otsu, Japan.
Acute submacular hemorrhage (SMH) can be caused by various diseases including age-related macular degeneration (AMD), polypoidal choroidal vasculopathy (PCV), and retinal arterial microaneurysm (RAM). The natural course of submacular hemorrhage is generally poor. Animal studies have suggested that the removal of subretinal hemorrhage may effectively reduce retinal damage caused by hemorrhage in humans and removal of submacular hemorrhage have been performed with limited visual outcomes.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!